Section 4.1: Laboratory Evaluation in Wound Care

Section 4.1: Laboratory Evaluation in Wound Care

Diagnostic laboratory testing provides vital systemic context for chronic wound management. While local wound care addresses tissue-level barriers such as slough, bacterial bioburden, and excessive exudate, healing cannot progress without an adequate systemic environment. Laboratory evaluation identifies underlying host impairments—including chronic protein-calorie malnutrition, uncontrolled diabetes mellitus, systemic infection, anemia, renal dysfunction, and coagulopathy—that frequently arrest wounds in a protracted inflammatory phase. Certified Wound Specialists (CWS) must systematically select, interpret, and integrate laboratory parameters to optimize patient outcomes and guide targeted interprofessional interventions.

---

Inflammatory Biomarkers in Clinical Wound Assessment

Systemic inflammatory markers provide valuable objective data regarding host immune response, deep-tissue tissue destruction, and response to antimicrobial or surgical management.

Erythrocyte Sedimentation Rate (ESR)

The Erythrocyte Sedimentation Rate (ESR) measures the distance in millimeters that red blood cells settle in uncoagulated anti-coagulated blood over one hour. In the presence of acute-phase proteins (primarily fibrinogen), erythrocytes form stacks (rouleaux) that settle rapidly. Normal baseline ESR ranges from 0 to 15 mm/hr for men and 0 to 20 mm/hr for women, increasing slightly with age.

In chronic wound care, ESR serves as a key adjunctive marker for deep osseous infection:

• Osteomyelitis Threshold: An ESR $> 70\text{ mm/hr}$ (or $> 60\text{ mm/hr}$ in diabetes) combined with clinical indicators such as a positive probe-to-bone (PTB) test or cortical erosion on X-ray strongly correlates with underlying osteomyelitis.
• Kinetics: ESR rises slowly following inflammatory stimuli (taking 24–48 hours) and remains elevated for weeks to months despite successful treatment due to the long half-life of circulating fibrinogen. Thus, ESR is valuable for initial screening but unreliable for rapid serial treatment monitoring.

C-Reactive Protein (CRP)

C-Reactive Protein (CRP) is an acute-phase reactant synthesized directly by hepatocytes in response to pro-inflammatory cytokines, specifically Interleukin-6 (IL-6), Interleukin-1 (IL-1), and Tumor Necrosis Factor-alpha (TNF-$\alpha$).

• Rapid Kinetics: Unlike ESR, CRP rises rapidly within 6 to 8 hours of acute tissue injury or bacterial invasion, peaking at 48 hours. Normal serum CRP is $< 3.0\text{ mg/L}$ ($< 0.3\text{ mg/dL}$). Marked elevations ($> 100\text{ mg/L}$) indicate severe systemic bacterial infection or necrotizing fascia.
• Serial Monitoring: Because CRP has a short elimination half-life of approximately 19 hours, serum levels fall rapidly as systemic inflammation resolves. Serial CRP measurements serve as the primary laboratory modality for evaluating response to surgical debridement or targeted systemic parenteral antibiotic therapy.

Procalcitonin (PCT)

Procalcitonin is a 116-amino acid peptide precursor of calcitonin. Under healthy physiological conditions, PCT is produced exclusively by thyroid neuroendocrine C-cells. However, during systemic bacterial infection, parenchymal cells throughout the body synthesize PCT in response to bacterial endotoxins and pro-inflammatory cytokines.

• Bacterial Specificity: PCT levels rise significantly ($> 0.5\text{ ng/mL}$) during invasive systemic bacterial infections but remain normal or minimally elevated during viral infections, localized non-invasive wound colonization, or autoimmune inflammation.
• Clinical Application: PCT guides systemic antibiotic stewardship, assisting clinicians in differentiating severe bacterial soft tissue infections from localized non-infectious inflammatory ulcers.

---

Complete Blood Count (CBC) & Oxygenation Parameters

Evaluation of cellular hematology is fundamental to assessing host defense mechanisms and peripheral tissue oxygenation capacity.

Leukocyte Dynamics & Differential

A standard Complete Blood Count (CBC) measures total white blood cells (normal range: 4,500–11,000 cells/mcL).

• Leukocytosis ($> 11,000\text{ cells/mcL}$): Suggests active infection, tissue necrosis, or systemic inflammation. A "left shift"—defined as an absolute band count $> 700/\text{mcL}$ or immature band forms comprising $> 10%$ of total leukocytes—signals rapid bone marrow release of immature neutrophils in response to severe acute bacterial infection (e.g., abscess, phlegmon, or necrotizing soft tissue infection).
• Leukopenia ($< 4,000\text{ cells/mcL}$): Indicates bone marrow suppression, severe overwhelming sepsis, or drug toxicity. Immunocompromised patients with leukopenia may fail to mount classic local signs of infection (calor, rubor, tumor, dolor), presenting instead with subtle wound deterioration.

Erythrocytic Indices & Tissue Oxygenation

Hemoglobin (Hb; normal female 12–16 g/dL, male 14–18 g/dL) and Hematocrit (Hct; normal female 37–48%, male 42–52%) dictate oxygen-carrying capacity. Collagen synthesis, fibroblast proliferation, and bacterial killing by neutrophil oxidative burst require adequate tissue oxygenation ($PaO_2 > 40\text{ mmHg}$ at the wound bed).

• Anemia (Hb $< 12\text{ g/dL}$): Decreases dissolved microvascular oxygen delivery. Chronic anemia impairs capillary budding and extracellular matrix (ECM) cross-linking.
• Differential Diagnosis: Microcytic anemia (MCV $< 80\text{ fL}$) suggests iron deficiency or chronic blood loss; normocytic anemia (MCV 80–100 fL) commonly reflects anemia of chronic disease/inflammation driven by elevated hepcidin; macrocytic anemia (MCV $> 100\text{ fL}$) indicates B12 or folate deficiency.

---

Nutritional Biomarker Panel & Visceral Proteins

Wound repair places immense metabolic demands on protein synthesis and micronutrient stores. Visceral protein markers must be interpreted alongside systemic inflammatory status.

Serum Albumin

Serum albumin (normal range: 3.5 to 5.0 g/dL) is the primary circulating protein synthesized by the liver, maintaining oncotic pressure and transporting hormones and medications.

• Long Half-Life: Albumin has a long circulating half-life of approximately 20 days, making it a marker of long-term baseline protein status over the preceding month.
• Inflammatory Confounding: Albumin is a negative acute-phase reactant. During acute inflammation or sepsis, hepatic protein synthesis shifts from albumin to acute-phase reactants (CRP, fibrinogen). Additionally, microvascular permeability increases, allowing albumin to leak into the interstitial space. Consequently, a low serum albumin ($< 3.0\text{ g/dL}$) during acute hospitalization reflects systemic inflammation and capillary leak as much as true protein malnutrition.

Prealbumin (Transthyretin)

Prealbumin (normal range: 16 to 35 mg/dL) is the preferred visceral protein marker for monitoring nutritional response in clinical wound management.

• Short Half-Life: Prealbumin has a short half-life of 2 to 3 days and a small circulating pool size, making it highly sensitive to acute changes in protein-calorie intake.
• Clinical Utility: Prealbumin accurately reflects early response to oral nutritional supplements, enteral nutrition, or parenteral nutrition within 3 to 5 days of initiation. A prealbumin level $< 10\text{ mg/dL}$ indicates severe protein malnutrition and high risk of wound healing failure.

Serum Transferrin & Total Lymphocyte Count

• Serum Transferrin: Half-life of 8 to 10 days (normal range: 200–400 mg/dL). While serving as an intermediate marker, transferrin levels rise in iron deficiency anemia, limiting its specificity as a pure nutritional metric.
• Total Lymphocyte Count (TLC): Calculated from the CBC ($%\text{Lymphocytes} \times \text{WBC} / 100$). A TLC $< 1,500\text{ cells/mm}^3$ indicates mild-to-moderate malnutrition and impaired cell-mediated immunity; a TLC $< 900\text{ cells/mm}^3$ reflects severe nutritional immunodeficiency and heightened wound breakdown risk.

Micronutrients & Trace Elements

• Vitamin C (Ascorbic Acid): Essential cofactor for prolyl and lysyl hydroxylase, enzymes responsible for collagen triple-helix stabilization. Deficiency causes scurvy, capillary fragility, and wound dehiscence.
• Vitamin A: Reverses the inhibitory effects of systemic corticosteroid therapy on wound healing by stimulating macrophage activation, epithelialization, and fibronectin synthesis.
• Zinc: Required cofactor for matrix metalloproteinases (MMPs), DNA polymerase, and RNA polymerase. Deficiency causes impaired epithelial cell migration, reduced tensile strength, and blunted immune response.

---

Glycemic Control & Metabolic Profiling

Uncontrolled blood glucose severely impairs cellular kinetics, microvascular perfusion, and structural tissue repair.

Hemoglobin A1c (HbA1c)

Hemoglobin A1c measures the percentage of hemoglobin glycated over the average erythrocyte lifespan (90–120 days). The ABWM clinical target for optimal wound healing in adults with diabetes is $ ext{HbA1c} < 7.0%$.

• Pathophysiology of Hyperglycemia: HbA1c levels $> 8.0%-9.0%$ lead to non-enzymatic glycation of tissue proteins, forming Advanced Glycation End-products (AGEs). AGEs cross-link collagen, causing microvascular basement membrane thickening and arterial wall stiffness.
• Cellular Suppression: Hyperglycemia blunts neutrophil chemotaxis, phagocytosis, and intracellular superoxide oxidative burst, dramatically increasing susceptibility to soft tissue and bone infections.

Acute Hyperglycemia & Cellular Dysfunction

Bedside blood glucose values $> 180\text{--}200\text{ mg/dL}$ acutely impair leukocyte phagocytic function. Glycemic variability with frequent glycemic spikes delays macrophage transition from the pro-inflammatory M1 phenotype to the pro-healing M2 phenotype.

---

Renal Function & Hydration Biomarkers

Renal insufficiency directly impacts tissue hydration, systemic toxin accumulation, and vascular integrity.

BUN, Creatinine, and eGFR

• Blood Urea Nitrogen (BUN; 7–20 mg/dL) & Creatinine (0.6–1.2 mg/dL): Elevated BUN with normal creatinine (BUN/Cr ratio $> 20:1$) indicates prerenal azotemia secondary to systemic dehydration. Dehydration causes peripheral vasoconstriction, diminishing microvascular perfusion to cutaneous wounds.
• Estimated Glomerular Filtration Rate (eGFR): An eGFR $< 60\text{ mL/min/1.73m}^2$ defines chronic kidney disease (CKD). Stage 5 CKD/End-Stage Renal Disease (ESRD; eGFR $< 15\text{ mL/min/1.73m}^2$) significantly alters wound repair.

Renal Failure & Wound Biology

ESRD patients experience uremic platelet dysfunction, chronic low-grade inflammation, impaired Clearance of nephrotoxic topicals/systemic antibiotics, and an extreme risk for Calciphylaxis (Calcific Uremic Arteriolopathy) when serum calcium-phosphate ion product ($[\text{Ca}] \times [\text{PO}_4]$) exceeds $55\text{ mg}^2/\text{dL}^2$.

---

Coagulation & Hematologic Hemostasis

Hemostasis is the mandatory first phase of wound repair; however, coagulation abnormalities can severely impair microvascular blood flow or pose surgical bleeding risks during debridement.

PT/INR, aPTT & Debridement Safety

• Prothrombin Time (PT) / International Normalized Ratio (INR): Evaluates extrinsic and common coagulation pathways. Therapeutic INR ranges from 2.0 to 3.0 for patients on Warfarin. Prior to aggressive sharp debridement, INR values $> 2.5\text{--}3.0$ require clinical caution to avoid uncontrollable focal hemorrhage.
• Activated Partial Thromboplastin Time (aPTT): Evaluates intrinsic and common pathways (normal 25–35 seconds). Useful for monitoring unfractionated heparin therapy.

Hypercoagulability Workup

In patients presenting with atypical retiform purpura, livedo reticularis, or painful ischemic skin necrosis without macrovascular peripheral artery disease, hypercoagulability screening is indicated:

• Protein C and Protein S deficiency
• Antithrombin III deficiency
• Factor V Leiden mutation
• Antiphospholipid antibodies (Lupus Anticoagulant, Anticardiolipin, Anti-$\beta_2$-glycoprotein I)

---

Summary Table: Visceral Protein Biomarkers in Wound Care